Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-006373
Filing Date
2021-01-29
Accepted
2021-01-29 21:46:49
Documents
1
Period of Report
2021-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3954
  Complete submission text file 0001209191-21-006373.txt   5312
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Issuer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94014
Business Address
Dias Subaweerage (Reporting) CIK: 0001825443 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39594 | Film No.: 21574031